)
NeoGenomics (NEO) investor relations material
NeoGenomics Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Clinical business performance and growth drivers
Clinical volume increased by 15% and revenue by 18%, with NGS now comprising about a third of clinical revenue.
Sales force investments and improved customer experience have driven both retention and new business growth.
NGS segment saw 24% growth, attributed to community market focus and new product launches like PanTracer LBX, expected to further boost growth into 2026.
Pathline acquisition expands presence in the Northeast, an underpenetrated region, supporting further market share gains.
Portfolio streamlining and rebranding under PanTracer Family have led to category growth across solid tumor, HRD, and liquid biopsy products.
Product innovation and future launches
RaDaR ST will launch in 2026 with initial indications in head and neck and breast cancer, with additional indications expected later that year.
PanTracer LBX is anticipated to contribute significantly to NGS growth in 2026, with reimbursement expected after a 12-month MolDX review cycle.
Ongoing enhancements to the digital platform, including updated portals and future app development, aim to improve customer integration and experience.
New tests like c-MET and Claudin-18 are being added to address emerging therapy needs.
Biopharma and non-clinical business outlook
Biopharma revenue, about 6% of total, has declined for two years and is expected to see modest erosion through 2026, with growth targeted for 2027 and beyond.
New leadership and portfolio offerings like RaDaR ST and Palettra are expected to support a turnaround.
Pharma cycles are longer, with meaningful patient flow from new products expected in late 2026.
Next NeoGenomics earnings date
Next NeoGenomics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)